Zhangshang Tangyi Funding, Investors & Competitors

Zhangshang Tangyi has raised $275M across 4 funding rounds, most recently a $144M Series D in January 2020.

Last Zhangshang Tangyi funding round

$144M

Series D · Jan 2020

Cumulative funding Zhangshang Tangyi raised

$275M

across 4 funding rounds

Key investors in Zhangshang Tangyi

  • IDG Capital
  • LB Investment
  • Ping An Ventures
  • Matrix Partners China
  • SIG China (SIG Asia Investments)
  • Samsung Ventures
  • CICC
  • CMB International Capital Corporation

Zhangshang Tangyi Overview

About Zhangshang Tangyi

Zhangshang Tangyi is a health management platform in China focused on diabetes care. Hangzhou-based and founded in 2014, it allows patients to upload glucose readings via apps, receiving doctor guidance. The platform connects 100,000 users with 5,000 physicians across Zhejiang province.


Founded

2014

HQ

ChinaHangzhou

Status

Privately held

Customer focus

B2B & B2C

Revenue model

Subscription

Zhangshang Tangyi Funding History

Zhangshang Tangyi has raised a total of $275M across 4 funding rounds.

Zhangshang Tangyi's first fundraising round was a $15M Series A in October 2015. The most recent completed round was a $144M Series D in January 2020.

Zhangshang Tangyi funding rounds

Zhangshang Tangyi funding rounds
DateStageInvestorsRaisedDeal Summary
Jan 2020Series DCMB International Capital Corporation (lead); SIG China (SIG Asia Investments) (lead); Tasly; CLP Data Services; LB Investment; Oriental Patron; Bojiang Capital$144MZhangshang Tangyi is a health management platform focused on diabetes, founded in 2014 and based in Hangzhou, Zhejiang. It enables patients to upload health data via a mobile app and receive treatment guidance from doctors.
Jan 2019Series CCICC (lead); IDG Capital; Meinian Onehealth; Samsung Ventures; LB Investment; Tasly Pharmaceutical; China Capital Investment Group; Ping An Ventures$100MZhangshang Tangyi is a health management platform focused on diabetes management, enabling patients to upload health data for monitoring and care. On July 1, 2019, it raised $100 million in a funding round led by CICC, with participation from China Capital Investment Group, Health 100, IDG Capital, LB Investment, Ping An Ventures, Samsung Ventures, and Tasly Pharmaceutical, at a post-money valuation of $130.79 million. This deal was highlighted in the InsurTech sector as part of Q1 2019's record activity, including high volumes of Series B and C rounds.
Mar 2018Series BTianyi Group (lead)$16M-
Oct 2015Series AIDG Capital (lead); Matrix Partners China; Ping An Ventures$15M-

Who has invested in Zhangshang Tangyi?

16 investors have backed Zhangshang Tangyi across its funding rounds, including IDG Capital, LB Investment, Ping An Ventures, Matrix Partners China, SIG China (SIG Asia Investments) and Samsung Ventures.

Lead investors include CMB International Capital Corporation, SIG China (SIG Asia Investments), CICC, Tianyi Group and IDG Capital.


Zhangshang Tangyi Investors

Investors in Zhangshang Tangyi by funding rounds participated
InvestorHQRoundsRoleFirst check
IDG CapitalChinaBeijing2LeadOct 2015
LB InvestmentSouth KoreaSouth Korea2ParticipantJan 2019
Ping An VenturesChinaShanghai2ParticipantOct 2015
Matrix Partners ChinaChinaBeijing1ParticipantOct 2015
TaslyChinaTianjin1ParticipantJan 2020
CLP Data ServicesChinaHong Kong1ParticipantJan 2020
Meinian OnehealthChinaShanghai1ParticipantJan 2019
Tianyi GroupChinaShanghai1LeadMar 2018
Samsung VenturesSouth KoreaSouth Korea1ParticipantJan 2019
CICCChinaBeijing1LeadJan 2019
Tasly PharmaceuticalChinaTianjin1ParticipantJan 2019
Oriental PatronHong KongHong Kong1ParticipantJan 2020
CMB International Capital CorporationHong KongHong Kong1LeadJan 2020

This data is available for Pro users. Sign up to see all 16 Zhangshang Tangyi investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Zhangshang Tangyi Competitors

Zhangshang Tangyi competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.

Public and private companies comparable to Zhangshang Tangyi
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
IQVIAUnited StatesUnited StatesPublicly listed$16B$3.4B$44B3.4x
VeevaUnited StatesUnited StatesPublicly listed$3.2B$965M$43B10.2x
IDEXX LaboratoriesUnited StatesUnited StatesPublicly listed$4.3B$1.5B$40B8.9x
Roper TechnologiesUnited StatesUnited StatesPublicly listed$7.9B$3.2B$37B5.7x
CommureUnited StatesSan Francisco, CAPrivate$200M-$7B35.0x
DoctolibFranceParisPrivate$400M-$6.4B16.0x

Zhangshang Tangyi Public Comps

Zhangshang Tangyi is still privately-owned, but its public comps include Garmin, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging and Glaukos.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Garmin$7.2B$2.1B7.0x6.4x24.4x21.7x
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Veeva$3.2B$965M11.1x10.2x36.9x22.4x
IDEXX Laboratories$4.3B$1.5B9.5x8.9x27.1x24.9x
Roper Technologies$7.9B$3.2B6.1x5.7x15.2x14.6x
GE HealthCare$21B$3.7B1.8x1.8x10.1x10.0x
ICON plc$8.3B$816M1.9x1.9x19.2x11.3x
Pro Medicus$186M$147M66.6x62.7x84.4x77.6x

This data is available for Pro users. Sign up to see all Zhangshang Tangyi competitors and their valuation data.

Start Free Trial

Common questions about Zhangshang Tangyi

When was Zhangshang Tangyi founded?Zhangshang Tangyi was founded in 2014.
Where is Zhangshang Tangyi headquartered?Zhangshang Tangyi is headquartered in Hangzhou, China.
Is Zhangshang Tangyi publicly listed?No, Zhangshang Tangyi is a private, VC-backed company.
How much funding has Zhangshang Tangyi raised?Zhangshang Tangyi has raised $275M across 4 funding rounds.
What was Zhangshang Tangyi's last funding round?Zhangshang Tangyi's last funding round was a $144M Series D in January 2020, led by CMB International Capital Corporation and SIG China (SIG Asia Investments).
Who are Zhangshang Tangyi's investors?Zhangshang Tangyi's investors include IDG Capital, LB Investment, Ping An Ventures, Matrix Partners China, Tasly, CLP Data Services, Meinian Onehealth, Tianyi Group, Samsung Ventures, CICC and 6 others.
Which companies are comparable to Zhangshang Tangyi?Companies comparable to Zhangshang Tangyi include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib.

See companies similar to Zhangshang Tangyi

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial